tiprankstipranks
Trending News
More News >
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
Advertisement

Day One Biopharmaceuticals (DAWN) Ownership - Who Owns Day One Biopharmaceuticals?

Compare
350 Followers

Day One Biopharmaceuticals (DAWN) Ownership Overview

3.97%21.96%28.79%11.08%34.20%
28.79% Other Institutional Investors
11.08% ETFs
34.20% Public Companies and
Individual Investors
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail, and individual investors. Approximately 61.83% of the company’s stock is owned by Institutional Investors, 3.97% is owned by Insiders, and 34.20% is owned by Public Companies and Individual Investors.
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail, and individual investors. Approximately 50.75% of the company’s stock is owned by Institutional Investors, 3.97% is owned by Insiders, and 11.08% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,755,577Institution5.62%38,850,145
5,259,986Institution5.14%35,504,906
5,024,867Institution4.91%33,917,852
3,723,131Institution3.63%25,131,134
3,329,091Institution3.25%22,471,364
3,219,302Institution3.14%21,730,289
3,103,448Institution3.03%20,948,274
2,558,563Institution2.50%17,270,300
2,334,142Institution2.28%15,755,459
2,114,006Institution2.06%14,269,541

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,024,867Institution4.91%33,917,852
3,219,302Institution3.14%21,730,289
2,334,142Institution2.28%15,755,459
1,865,766Institution1.82%12,593,921
1,461,238Institution1.43%9,863,357
1,395,300Institution1.36%9,418,275
1,367,692Institution1.34%9,231,921
936,000Institution0.91%6,318,000
780,859Institution0.76%5,270,798
607,465Institution0.59%4,100,389

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,386,942Institution2.33%16,016,381
1,687,841Institution1.65%11,392,927
1,251,255Institution1.22%7,820,344
922,244Institution0.90%6,188,257
752,754Institution0.73%5,050,979
598,884Institution0.58%4,018,512
592,426Institution0.58%3,998,876
463,442Institution0.45%3,128,234
343,821Institution0.34%2,307,039
320,501Institution0.31%2,003,131

FAQ

Who Owns Day One Biopharmaceuticals (DAWN)?
According to the latest TipRanks data, approximately 28.79% of the company's stock is held by institutional investors, 3.97% is held by insiders, and 34.20% is held by retail investors.
    What percentage of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 28.79% of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors.
      What percentage of Day One Biopharmaceuticals (DAWN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 34.20% of Day One Biopharmaceuticals (DAWN) stock is held by retail investors.
        Who owns the most shares of Day One Biopharmaceuticals (DAWN)?
        Peter Kolchinsky owns the most shares of Day One Biopharmaceuticals (DAWN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis